Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Ahnoff

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Frontiers in Nutrition|June 30, 2020
A Hydrogel Drink With High Fructose Content Generates Higher Exogenous Carbohydrate Oxidation and Lower Dental Biofilm pH Compared to Two Other, Commercially Available, Carbohydrate Sports DrinksStefan Pettersson, Martin Ahnoff, Fredrik Edin, et al.
Frontiers in Nutrition|September 25, 2020
Corrigendum: A Hydrogel Drink With High Fructose Content Generates Higher Exogenous Carbohydrate Oxidation and a Reduced Drop in Dental Biofilm pH Compared to Two Other, Commercially Available, Carbohydrate Sports DrinksStefan Pettersson, Martin Ahnoff, Fredrik Edin, et al.
Food & Function|December 4, 2019
Alginate and HM-pectin in sports-drink give rise to intra-gastric gelation in vivoLuca Marciani, Patricia Lopez-Sanchez, Stefan Pettersson, et al.
Contraception|June 20, 2019
A sensitive method detecting trace levels of levonorgestrel using LC-HRMSSandy Abujrais, Matts Olovsson, Martin Ahnoff, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|February 1, 2002
Determination of melagatran, a novel, direct thrombin inhibitor, in human plasma and urine by liquid chromatography-mass spectrometryMarita Larsson, Ulrika Logren, Martin Ahnoff, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 17, 2002
Determination of ximelagatran, an oral direct thrombin inhibitor, its active metabolite melagatran, and the intermediate metabolites, in biological samples by liquid chromatography-mass spectrometryMarita Larsson, Martin Ahnoff, Anna Abrahamsson, et al.
European Journal of Clinical Pharmacology|May 14, 2003
Pharmacokinetics and pharmacodynamics of ximelagatran, a novel oral direct thrombin inhibitor, in young healthy male subjectsUlf G Eriksson, Ulf Bredberg, Kristina Gislén, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 28, 2011
Development of a highly sensitive method using liquid chromatography-multiple reaction monitoring to quantify membrane P-glycoprotein in biological matrices and relationship to transport functionTasso Miliotis, Liaqat Ali, Johan E Palm, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 14, 2003
Absorption, distribution, metabolism, and excretion of ximelagatran, an oral direct thrombin inhibitor, in rats, dogs, and humansUlf G Eriksson, Ulf Bredberg, Kurt-Jürgen Hoffmann, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Frontiers in Nutrition|June 30, 2020
A Hydrogel Drink With High Fructose Content Generates Higher Exogenous Carbohydrate Oxidation and Lower Dental Biofilm pH Compared to Two Other, Commercially Available, Carbohydrate Sports DrinksStefan Pettersson, Martin Ahnoff, Fredrik Edin, et al.
Frontiers in Nutrition|September 25, 2020
Corrigendum: A Hydrogel Drink With High Fructose Content Generates Higher Exogenous Carbohydrate Oxidation and a Reduced Drop in Dental Biofilm pH Compared to Two Other, Commercially Available, Carbohydrate Sports DrinksStefan Pettersson, Martin Ahnoff, Fredrik Edin, et al.
Food & Function|December 4, 2019
Alginate and HM-pectin in sports-drink give rise to intra-gastric gelation in vivoLuca Marciani, Patricia Lopez-Sanchez, Stefan Pettersson, et al.
Contraception|June 20, 2019
A sensitive method detecting trace levels of levonorgestrel using LC-HRMSSandy Abujrais, Matts Olovsson, Martin Ahnoff, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|February 1, 2002
Determination of melagatran, a novel, direct thrombin inhibitor, in human plasma and urine by liquid chromatography-mass spectrometryMarita Larsson, Ulrika Logren, Martin Ahnoff, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 17, 2002
Determination of ximelagatran, an oral direct thrombin inhibitor, its active metabolite melagatran, and the intermediate metabolites, in biological samples by liquid chromatography-mass spectrometryMarita Larsson, Martin Ahnoff, Anna Abrahamsson, et al.
European Journal of Clinical Pharmacology|May 14, 2003
Pharmacokinetics and pharmacodynamics of ximelagatran, a novel oral direct thrombin inhibitor, in young healthy male subjectsUlf G Eriksson, Ulf Bredberg, Kristina Gislén, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 28, 2011
Development of a highly sensitive method using liquid chromatography-multiple reaction monitoring to quantify membrane P-glycoprotein in biological matrices and relationship to transport functionTasso Miliotis, Liaqat Ali, Johan E Palm, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 14, 2003
Absorption, distribution, metabolism, and excretion of ximelagatran, an oral direct thrombin inhibitor, in rats, dogs, and humansUlf G Eriksson, Ulf Bredberg, Kurt-Jürgen Hoffmann, et al.
Pageof 2